Alba Therapeutics (Larazotide Acetate Assets) Overview
Latest Deal Type
Alba Therapeutics (Larazotide Acetate Assets) General Information
Portfolio of assets related to a drug ingredient for celiac disease. The portfolio is comprised of assets relating to arazotide acetate, a tight junction modulator, progressing toward a Phase IIb clinical trial for the treatment of celiac disease.